Summary & Overview
HCPCS J0330: Injection, Succinylcholine Chloride up to 20 mg
HCPCS Level II code J0330 denotes the injection of succinylcholine chloride, up to 20 mg, a short-acting neuromuscular blocker commonly used to facilitate rapid-sequence intubation and brief procedural paralysis. Nationally, accurate coding of J0330 matters for procedural documentation, anesthetic drug utilization monitoring, and payer reimbursement for medication administration in acute care settings. Key payers discussed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will find a concise overview of clinical context for J0330, typical sites of service where the drug is administered, and the operational billing considerations that affect practice workflows. The publication includes payer coverage patterns and coding benchmarks, common modifier usage where data is available, and notes on documentation elements typically required to support billing for a neuromuscular blocking agent. Policy updates and national-level guidance relevant to billing and coding for injectable anesthetic adjuncts are summarized alongside practical billing scenarios to clarify potential coding pitfalls. Data not provided in the input, such as associated taxonomies, specific ICD-10 pairings, and payer-specific reimbursement rates, are identified as unavailable.
Billing Code Overview
HCPCS Level II code J0330 describes the injection of succinylcholine chloride, up to 20 mg. This code represents a short-acting neuromuscular blocking agent administered parenterally, typically used to facilitate endotracheal intubation and short procedures requiring muscle relaxation.
Service type: Injection / Medication administration
Typical site of service: Hospital inpatient or outpatient settings, ambulatory surgery centers, emergency departments, and procedural suites where rapid onset neuromuscular blockade is required
Clinical & Coding Specifications
Clinical Context
A typical patient is a 35-year-old adult scheduled for a short surgical procedure under general anesthesia, such as closed reduction of a fractured wrist or placement of a short-duration endotracheal tube for an emergent airway. The anesthesiologist or CRNA prepares rapid-onset neuromuscular blockade using J0330 (succinylcholine chloride, up to 20 mg) to facilitate endotracheal intubation. Pre-procedure workflow includes airway assessment, IV access confirmation, standard monitors placement, and documentation of allergies and contraindications (for example, history of malignant hyperthermia or neuromuscular disorders may contraindicate succinylcholine). The medication is drawn and charted in the medication administration record; the provider documents indication, dose, route (intravenous), and time of administration. Post-intubation care includes monitoring for apnea, fasciculations, serum potassium changes in at-risk patients, and reversal or supportive ventilation until spontaneous respiration returns. Billing for J0330 is appended to the anesthesia or procedural encounter where succinylcholine was administered for facilitation of airway management or brief neuromuscular blockade.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier (standard) | Use when no special circumstances apply to the service provided. |